8-K 1 p67142e8vk.htm 8-K e8vk
Table of Contents

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 28, 2002

LIPID SCIENCES, INC.

(Exact name of registrant as specified in its charter)

         
Delaware   0-497   43-0433090
 
 
(State or other jurisdiction of
incorporation)		   (Commission File
Number) 		  (I.R.S Employer
Identification No.)
     
7068 Koll Center Parkway, Suite 401, Pleasanton, California   94566
 
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (925) 249-4000

 

 

Item 7. Financial Statements and Exhibits
Item 9. Regulation FD Disclosure
SIGNATURE
EXHIBIT INDEX
EX-99.1

Table of Contents

Item 7. Financial Statements and Exhibits

(c) Exhibits

     
Exhibit   Description
 
99.1   Lipid Sciences, Inc. Press Release dated October 28, 2002

Item 9. Regulation FD Disclosure

         On October 28, Lipid Sciences, Inc., a Delaware corporation, issued a press release entitled “Lipid Sciences Inc. Announces Election of Dr. H. Bryan Brewer as Director.” The press release is attached to this Form 8-K as Exhibit 99.1 and is incorporated herein by reference.

          

 

Table of Contents

SIGNATURE

         Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Lipid Sciences, Inc.
         
Date: October 28, 2002   By:   /s/ Barry Michaels
       
    Name:   Barry Michaels
Title:   Chief Financial Officer
         

 

Table of Contents

EXHIBIT INDEX

     
Exhibit   Description
 
99.1   Lipid Sciences, Inc. Press Release dated October 28, 2002